IPHA News
February 8, 2021
€30m released for ‘backlogged’ medicines at same time as industry agrees new Agreement extension Patients to benefit from wider range of innovative treatment options under ‘bridging’ […]
January 31, 2021
Now is the time for collaboration and free movement on COVID-19 vaccines supply – IPHA The call for calm by the Taoiseach, Micheál Martin, on BBC’s Andrew Marr […]
January 27, 2021
Manufacturing billions of doses of COVID-19 vaccines for European citizens, including for people in Ireland, is a major challenge. Fluctuation in the supply of doses is frustrating – […]
January 25, 2021
Three-quarters of people will take COVID-19 vaccine, says Ipsos MRBI tracker survey for IPHA Biopharmaceutical industry says breakthroughs are guided by safety, quality and efficacy, and […]
January 11, 2021
Access to new treatments can be improved by sustainable, predictable Government budgeting, not by weakening intellectual property (IP) rights for medicines development, according to a submission […]
January 11, 2021
The Astellas plant in Killorglin, Co Kerry, is among the companies that feature in ‘Innovate For Life’ – the IPHA campaign that gives a platform to […]
January 11, 2021
Jennifer McCauliffe and Ellen Duggan of Takeda who were part of ‘Innovate’ For Life last year. IPHA’s new ‘Innovate For Life’ films tell ‘impact and value […]
January 10, 2021
AbbVie film welcomed as part of ‘Innovate For Life’ The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed a film highlighting the Irish work of AbbVie, one […]
December 1, 2020
Last week, the European Commission published a blueprint for the future of medicines innovation. The EU Pharmaceutical Strategy lays the foundation for a lively debate on […]